
Triton Partners exploring potential sale of Bormioli Pharma
Triton Partners is exploring the possibility of a sale of Bormioli Pharma, an Italian drug packaging company, in the coming months, three sources familiar with the situation said.
Goldman Sachs is prepping for a potential process, these sources said. A fourth source said that Goldman Sachs is testing the market, but was not aware that an official sellside mandate had yet been awarded.
Goldman Sachs assisted Triton, acting as joint global coordinator and joint bookrunner in the issue of a EUR 350m bond for Bormioli Pharma in May 2023.
Bormioli Pharma is expected to be marketed off around EUR 65m 2023 EBITDA, two of the sources said. In 2022, the company reported over EUR 315m of turnover, according to a company statement.
Both private equity firms with a background in the space and industry players will be invited to bid, one of the sources said.
Triton acquired Bormioli Pharma from Vision Capital for undisclosed terms in November 2017. At the time of the deal, the company had a turnover of EUR 217m.
Under Triton's ownership, Bormioli Pharma has grown organically and via M&A. In December 2020, it acquired ISO Arzneiverpackungen Gmbh, a German firm engaged in the production of pharmaceutical packaging, for an undisclosed sum. Earlier in March 2020, it bought GCL Pharma, a drug and cosmetic packaging firm, from Guala Closures for EUR 8.9m.
Triton Partners declined to comment. Bormioli Pharma and Goldman Sachs did not respond to requests for comment.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds